Onvy secures $ 2 million for revolutionary health platform!

Onvy secures $ 2 million for revolutionary health platform!

A spectacular step in the healthcare industry: The Onvy Healthtech Group from Munich has secured an impressive $ 2 million in a seed extension financing round to further expand its AI-supported Health coaching platform. This financing comes from Voloridge Health, part of the renowned hedge fund Voloridge Investment Management, which takes up a top position in the field of data -driven investments with $ 21 billion. This investment promises a new age in personalized health care, which is now revolutionized in real time, as onvy emphasizes.

The AI Health Coach in focus

The innovative platform of Onvy uses a system that analyzes biometric and behavior -related data in real time in order to provide immediately implementable recommendations to improve health. Adrian Kochsiek, founder and CEO of Onvy, explains: "The future of health is highly personalized, preventive and AI-supported." These technologies not only offer consumers, but also companies extensive insights into the health management of their employees. The platform will be of great importance for the challenges in the B2B sector, such as corporate wellness and prevention.

Voloridge Health, the supporter of this pioneering initiative, uses the latest data science to sustainably change health care. Your mission is to provide individuals and companies specifically with data -based knowledge that helps to recognize health risks at an early stage and take targeted preventive measures. David Vogel, co -founder of Voloridge Health, emphasizes that onvy sets a new benchmark for proactive health coaching with his approach and thus not only improves health, but also reduces costs in the long term and increases customer loyalty.

To learn more about this exciting development and the role of Voloridge Health in the healthcare industry, visit the Official website of Voloridge Health .

Details
OrtSchlossstrasse 19, 82031 Grünwald, Deutschland
Quellen

Kommentare (0)